JP6653037B2 - 水性液剤 - Google Patents

水性液剤 Download PDF

Info

Publication number
JP6653037B2
JP6653037B2 JP2019065250A JP2019065250A JP6653037B2 JP 6653037 B2 JP6653037 B2 JP 6653037B2 JP 2019065250 A JP2019065250 A JP 2019065250A JP 2019065250 A JP2019065250 A JP 2019065250A JP 6653037 B2 JP6653037 B2 JP 6653037B2
Authority
JP
Japan
Prior art keywords
salt
aqueous solution
acid
preservative
buffer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2019065250A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019182848A (ja
Inventor
涼香 家本
涼香 家本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Original Assignee
Senju Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd filed Critical Senju Pharmaceutical Co Ltd
Publication of JP2019182848A publication Critical patent/JP2019182848A/ja
Application granted granted Critical
Publication of JP6653037B2 publication Critical patent/JP6653037B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
JP2019065250A 2018-03-30 2019-03-29 水性液剤 Active JP6653037B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018066378 2018-03-30
JP2018066378 2018-03-30

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020009831A Division JP6802936B2 (ja) 2018-03-30 2020-01-24 水性液剤

Publications (2)

Publication Number Publication Date
JP2019182848A JP2019182848A (ja) 2019-10-24
JP6653037B2 true JP6653037B2 (ja) 2020-02-26

Family

ID=68061910

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2019065250A Active JP6653037B2 (ja) 2018-03-30 2019-03-29 水性液剤
JP2020009831A Active JP6802936B2 (ja) 2018-03-30 2020-01-24 水性液剤
JP2020148292A Active JP7438899B2 (ja) 2018-03-30 2020-09-03 水性液剤
JP2024020182A Active JP7839818B2 (ja) 2018-03-30 2024-02-14 水性液剤
JP2025207302A Pending JP2026020360A (ja) 2018-03-30 2025-11-27 水性液剤

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2020009831A Active JP6802936B2 (ja) 2018-03-30 2020-01-24 水性液剤
JP2020148292A Active JP7438899B2 (ja) 2018-03-30 2020-09-03 水性液剤
JP2024020182A Active JP7839818B2 (ja) 2018-03-30 2024-02-14 水性液剤
JP2025207302A Pending JP2026020360A (ja) 2018-03-30 2025-11-27 水性液剤

Country Status (2)

Country Link
JP (5) JP6653037B2 (https=)
WO (1) WO2019189720A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6653037B2 (ja) * 2018-03-30 2020-02-26 千寿製薬株式会社 水性液剤
JP2020033290A (ja) * 2018-08-29 2020-03-05 興和株式会社 水性組成物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH092517A (ja) * 1995-06-26 1997-01-07 Taisho Pharmaceut Co Ltd 液状薬剤の包装用材料
US6211238B1 (en) * 1998-10-27 2001-04-03 Alcon Laboratories, Inc. Preservative system for topically administrable pharmaceutical compositions
JP2001206454A (ja) * 2000-01-24 2001-07-31 Material Eng Tech Lab Inc 抗菌性容器
JP4580524B2 (ja) * 2000-09-12 2010-11-17 株式会社日本点眼薬研究所 フィルター付き吐出容器
JP4357159B2 (ja) * 2002-07-22 2009-11-04 ニプロ株式会社 薬液容器
JP4574236B2 (ja) * 2004-06-07 2010-11-04 ロート製薬株式会社 容器の注出口構造及び包装用容器
US8034813B2 (en) 2008-11-18 2011-10-11 Bausch & Lomb Incorporated Polymorphs of brimonidine pamoate
US20120312840A1 (en) * 2011-05-13 2012-12-13 Ayako Hasegawa Container closure system with integral antimicrobial additives
CN103006662A (zh) 2011-09-20 2013-04-03 北京秦武田制药有限公司 用于局部眼科应用的溴莫尼定和倍他洛尔组合物
PL3179982T3 (pl) * 2014-07-28 2023-09-25 Sun Pharma Advanced Research Company Ltd Sposób zwiększenia biodostępności i/lub przedłużenia działania oftalmicznego leku
JP2016132465A (ja) * 2015-01-19 2016-07-25 参天製薬株式会社 点眼容器
KR20170132725A (ko) * 2015-02-24 2017-12-04 더 보오드 오브 트러스티스 오브 더 유니버시티 오브 일리노이즈 안구 건조 질환 및 다른 안과 질환을 치료하기 위한 방법 및 조성물
CN108601763A (zh) * 2016-02-22 2018-09-28 参天制药株式会社 含有多佐胺和溴莫尼定的药物组合物
JP6495379B2 (ja) * 2016-06-15 2019-04-03 興和株式会社 水性の組成物
JP7120789B2 (ja) * 2017-09-29 2022-08-17 積水化学工業株式会社 水性ポリビニルアセタール樹脂組成物
JP6653037B2 (ja) 2018-03-30 2020-02-26 千寿製薬株式会社 水性液剤

Also Published As

Publication number Publication date
JP6802936B2 (ja) 2020-12-23
JP2019182848A (ja) 2019-10-24
WO2019189720A1 (ja) 2019-10-03
JP2024040421A (ja) 2024-03-25
JP2020059761A (ja) 2020-04-16
JP7438899B2 (ja) 2024-02-27
JP2020193233A (ja) 2020-12-03
JP2026020360A (ja) 2026-02-06
JP7839818B2 (ja) 2026-04-02

Similar Documents

Publication Publication Date Title
JP6621955B2 (ja) 水性液剤
JP7839818B2 (ja) 水性液剤
JP6009141B2 (ja) 水性組成物
JP2015147763A (ja) ピリジルアミノ酢酸化合物含有医薬組成物
JP6797992B1 (ja) 水性液剤
JP7673154B2 (ja) 眼科用組成物
JP6012231B2 (ja) ブロムフェナク含有組成物
JP7269425B2 (ja) 水性液剤
JP7447072B2 (ja) 水性液剤
JP6213715B2 (ja) 多成分配合点眼剤
JP6628924B2 (ja) 水性液剤
JP6901619B2 (ja) 水性液剤
WO2011027778A1 (ja) 高眼圧症および緑内障処置のための眼局所投与用組成物
JP2026069651A (ja) 水性液剤
TW202404569A (zh) 含有賽佩普斯特(Sepetaprost)之眼科用組合物
JP2016041749A (ja) シリコーンハイドロゲルコンタクトレンズ用眼科組成物
JP2016006044A (ja) 水性製剤

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190703

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190703

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20190703

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20190718

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190820

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190913

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20191023

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20191218

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20191218

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20200121

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20200124

R150 Certificate of patent or registration of utility model

Ref document number: 6653037

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250